Residency · Bowling Green, KY
Sponsored by University of Kentucky College of Medicine
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 358 citations · Frederick Ueland
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy.
Cancers · 2022 · 103 citations · Frederick Ueland
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Gynecologic oncology · 2025 · 23 citations · Frederick Ueland
Human macrophage-engineered vesicles for utilization in ovarian cancer treatment.
Frontiers in oncology · 2022 · 34 citations · Frederick Ueland
Congenital Syphilis Diagnosed Beyond the Neonatal Period in the United States: 2014-2018.
Pediatrics · 2021 · 34 citations · Aliza Machefsky
Risk of adverse perinatal outcomes in pregnancies with "small" fetuses not meeting Delphi consensus criteria for fetal growth restriction.
American journal of obstetrics and gynecology · 2023 · 15 citations ·
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 18 citations · Frederick Ueland
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study.
Gynecologic oncology · 2025 · 11 citations · Frederick Ueland